Clinical trial · Interventional
Patient Experience and Acceptance of Horizontal Rotation
Nano-X: Patient Experience and Acceptance of Horizontal Rotation
NCT02995603CI-TRIAL-00112000Nano-XterminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Ongoing funding ceased
Summary
Brief summary (as posted)
Patients will complete validated psychometric questionnaires to quantify their experience of being rotated at different speeds using the Nano-X patient rotation system.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Nano-X patient rotation | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Patient rotation
- description
- Patients will be rotated horizontally, using the Nano-X patient rotation system, and asked to complete validated questionnaires to quantify their experience.
- interventionNames
- Device: Nano-X patient rotation
Primary outcomes (3)
- measure
- Change in level of patient anxiety following rotation in the Nano-X Patient Rotation System
- timeFrame
- 1 hour
- description
- Comparison of mean scores of Short Form State/Trait Anxiety Inventory (STAI) Questionnaire outcomes before and after being rotated in the Nano-X Patient Rotation System
- measure
- Change in level of patient motion sickness following rotation in the Nano-X Patient Rotation System
- timeFrame
- 1 hour
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. A diagnosis of cancer, any stage 2. ≥18 years of age 3. Eastern Cooperative Oncology Group (ECOG) status 0-2 4. Currently or previously being treated with radiotherapy 5. Any prior therapy allowed 6. Willing and able to comply with all study requirements 7. Must be able to read and complete questionnaires in English 8. Signed, written informed consent Exclusion Criteria: 1. Pregnant women 2. Mentally impaired patients or patients for whom attaining informed consent would be difficult (including language barriers) 3. Severe vertigo or recent diagnosis of Benign Paroxysmal Positioning Vertigo
References
Publications (0)
Data not yet available
No reference posted for this study.